Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CVBT/VT is in default in the state of Delaware and Nevada. It is no longer a legitimate corporation by any definition. Any attempt to raise money for an illegitimate corporation is fraud and a crime.
If you are someone you know is being contacted to put money into this company please contact the State of Nevada and/or Delaware's Department of Corporations Enforcement Division.
That is the status of the raise.
Perhaps you did not understand, it is no longer speculation.
The Nevada Secretary of State officially lists that VT is in default.
The State of Delaware states that VT has yet to file their taxes.
This is official records, Venturis Therapeutics has died. Administrators like Grant Gordon who were trying to boost the stock in September despite the corporation officially being in default in March seem to be liable for fraud.
Venturis is now officially dead, the Nevada Secretary of State said it in March, the Federal Court said it in April, and the state of Delaware said it in May.
There is no more speculation. VT is dead.
This can be found on official state websites, the company has legitimately and officially gone into default. But you're right the company website is up.
Venturis Therapeutics’ Official Default
My email has been battered today with news I had never imagined. Somehow it always gets worse for us shareholders at CVBT/VT.
Venturis’ phone number, 972-681-9368, has been disconnected and is no longer in service.
The Nevada Secretary of State’s website shows that Venturis Therapeutics has a status of “in default” as a result of its failure to file its annual list on May 31, 2021.
According to the state of Delaware, Venturis Therapeutics is also delinquent in the state of Delaware for its failure to pay its taxes as of March 2021.
It looks like the CVBT/VT administration is attempting to boost the stock with meaningless press-releases and questionable financing operations while slowly shutting down the company as they did with their press-release in September 2021.
Are the company administrators liable for fraud after attempting to boost the stock price despite knowing that the company was officially in default, failed to pay its taxes, and has a disconnected phone service, making it impossible to contact the offices? Could Grant Gordon and other administrators have the corporate veil pierced as a result of this clearly fraudulent and misleading information, giving the façade of business activity despite the slow shutdown of company offices, phone numbers, and failing to pay company fees and taxes??
CVBT/VT does not even have drug yet, that is a half-decade process (approximately 5 years), they have no medical experts whatsoever that are capable to make the drug. I am doubtful that we will ever start clinical trials again.
Absolutely, CVBT/VT has epitomized what it means to progress as a biotech company. To celebrate the administration's seven-success since 2014, I have compiled a list highlighting some of their greatest achievements:
1. Lose every lawsuit to the former administration
2. Owe $1,000,000 to the former administration in a non-offsettable-judgement by the US Federal Court
3. Lose their legal representation because they had an inability to pay $200,000 in legal fees.
4. Have federal court records say that the company is completely valueless, has no revenue streams and no assets.
5. Has yet to make any progress what so ever in clinical trials.
6. Has yet to produce the drug they need for clinical trials
7. Has somehow downgraded their office space
8. Has signed a deal with a nobody company to secure the last $1 million dollars of the $100 million (if not more) that they need to raise.
9. Have their entire administration accused of fraud.
10. Have the CEO accused of embezzling money by the US Government
11. Have a known alcoholic run the PR at this forum.
12. File worthless patents
13. Attempting to sell highly-questionable convertible notes to innocent investors
Since this company is clearly moving in the right direction (if that direction is liquidation and bankruptcy), then why must our administration make fake news and try to argue that the stock is worth anything more than $0.01 per share, if that.
CVBT/VT is over. Expect another press release on this forum in another 6 months, maybe then they can raise a few pennies!
CVBT/VT LAWYERS ADMIT CVBT/VT IS WORTHLESS IN FEDERAL COURT
The truth about Cardiovascular Biotherapeutics/Venturis Therapeutics is coming out as a result of the lawsuit they have filed against our former administration.
Our own lawyers were forced to withdraw themselves from the case as a result of Cardiovascular Biotherapeutics'/Venturis Therapeutics' inability to pay the company's lawyers.
As bad as that may sound, this is not all, the company's lawyer then went on to state: Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
Our own lawyers admitted in Federal District Court the incompetence of our administration. We are a worthless company. The United States Federal Court states it in their records, our own lawyers state it, our former administrative members say it.
Cardiovascular Biotherapeutics/Venturis Therapeutics is officially worthless.
"it has become evident that there are currently no assets or revenue streams from which payments can be made."
It gets worse. Not only did our company's lawyers withdraw themselves from Cardiovascular Biotherapeutics/Venturis Therapeutics' lawsuit in federal court, they have also emphasized how defunct Venturis Therapeutics/CVBT truly is in a statement to the United States Federal Court. I have posted another excerpt:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 23-25 read as follows:
"Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made."
"...unpaid fees in excess of $200,000..."
I was able to get my hands on some court documents and was able to find more about why CVBT/VT's lawyers have withdrawn themselves from their suit in Federal District Court. It appears that we did not have enough money to pay them. I have posted an excerpt here:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 15-17 are as follows:
Further, as of March 31, 2021, Venturis owed Mr. Cannaday’s law firm, Dentons US LLP (“Dentons”), unpaid fees in excess of $200,000 for representation in this Previously Closed Case and for representation in the underlying arbitration.
"Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement."
I have managed to obtain some court documents further ellaborating why our company's lawyer has withdrawn himself from the case. I have posted an excerpt here:
UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC.,
formerly known as CARDIOVASCULAR
BIOTHERAPEUTICS, INC.
Claimant,
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN
THE ALTERNATIVE, MOTION TO
WITHDRAW AS COUNSEL FOR
VENTURIS THERAPEUTICS, INC.
Page 3, Line 16 Reads as follows:
However, Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement.
$1,100,000 awarded to Daniel C. Montano by the US Federal Court against CVBT/VT
The United States Federal court has confirmed Daniel C. Montano's $1.1 million dollar judgement against CVBT/VT as a result of their fraudulent and frivolous lawsuit claiming that Daniel C. Montano's IP was not his.
The US Federal Court not only confirmed that Daniel C. Montano has a $1 million dollar (non-off-settable) judgement against CVBT/VT, but that Daniel C. Montano and Zhittya Genesis Medicine own all of their IP.
Daniel C. Montano announces that the US Federal Court has confirmed his IP
The United States Federal Court has confirmed the ruling in favor of Daniel C. Montano citing that Dan Montano owns all of the IP that he and his company, Zhittya Genesis Medicine are developing.
The United States Federal Court's confirmation comes as a result of Cardiovascular Biotherapeutics/ Venturis Therapeutics' own management team testifying in favor of Daniel C. Montano, stating that the IP that Dan Montano and Zhittya Genesis Medicine have been developing are 100% theirs.
Daniel C Montano Announces His Victory over CVBT/VT
Despite years of fraudulent and frivolous lawsuits it appears that Daniel C Montano is now victorious over the crooks that run Cardiovascular Biotherapeutics/Venturis Therapeutics.
Daniel C. Montano has been awarded an over $1 million dollar judgment against CVBT/VT as a result of the frivolous lawsuit that they had originally filed.
Daniel C. Montano's more than $1,000,000 dollar judgement against Cardiovascular BioTherapeutics/Venturis Therapeutics has been confirmed by the United States Federal Court System.
Dan Montano's clear victory over CVBT/VT could result in a forced debtors exam against CVBT/VT in order for Montano to collect on his judgement.
Daniel C Montano has announced that he has won a $1 million dollar judgement against CVBT
Daniel C. Montano has announced that he has won a $1 million dollar judgement against Cardiovascular Biotherapeutics/Venturis Therapeutics confirmed by the US Federal Court. The judge dismissed all of CVBT/VT's claims against Dan Montano. Our current administration's takeover in 2014 has resulted in CVBT/VT suing Daniel C. Montano 10 different times to stop him from developing FGF-1. Each time CVBT/VT has lost to Daniel C. Montano, resulting in astounding victories for Dan Montano.
CVBT/VT's three biotech experts all independently testified that Dan Montano was innocent from the fraudulent claims made by CVBT/VT management.
The most recent court judgement has not only given Daniel C. Montano the ability to actively pursue the fraudulent claimants in order to satisfy his $1 million dollar judgement, but also has given Dan Montano the ability to actively focus on developing FGF-1 at Zhittya Genesis Medicine which has now initiated two Phase I Clinical Trials in Parkinson's Disease and ALS.
Daniel C Montano announces that he wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021
Daniel C. Montano announced that he has won a judgement against CVBT/VT
Daniel C. Montano has announced that he has won a $1 million dollar judgement against Cardiovascular Biotherapeutics/Venturis Therapeutics confirmed by the US Federal Court. The judge dismissed all of CVBT/VT's claims against Dan Montano. Our current administration's takeover in 2014 has resulted in CVBT/VT suing Daniel C. Montano 10 different times to stop him from developing FGF-1. Each time CVBT/VT has lost to Daniel C. Montano, resulting in astounding victories for Dan Montano.
CVBT/VT's three biotech experts all independently testified that Dan Montano was innocent from the fraudulent claims made by CVBT/VT management.
The most recent court judgement has not only given Daniel C. Montano the ability to actively pursue the fraudulent claimants in order to satisfy his $1 million dollar judgement, but also has given Dan Montano the ability to actively focus on developing FGF-1 at Zhittya Genesis Medicine which has now initiated two Phase I Clinical Trials in Parkinson's Disease and ALS.
Daniel C. Montano has initiated a Debtor's Exam against CVBT/VT
Daniel C. Montano has initiated a Debtor's Exam against CVBT/VT, within the next 30 days the shareholders will know that CVBT/VT has no financial viability and is an empty shell of a company.
I fear that Dan Montano will seize all of the assets, including IP, that CVBT has and will sue the CVBT/VT directors for their actions.
DEBTORS EXAM FOR CARDIOVASCULAR BIOTHERAPEUTICS (CVBT)/VENTURIS THERAPEUTICS
Rumor has it that as a result of Dan Montano's court victory, which has given him a judgment of a $1 million dollar claim against Venturis Therapeutics, confirmed by the Federal Court, that Dan Montano will be seeking a debtors exam for CVBT in the month of May. I am worried that this debtors exam will reveal the true financial position of CVBT/Venturis Therapeutics and make the CVBT directors liable.
How will this debtor's exam affect the future of CVBT? Will there be a future for CVBT following this major legal victory for Daniel C. Montano? Where will CVBT get the $1 million dollars to pay Mr. Dan Montano?
THE UNITED STATES FEDERAL COURT HAS CONFIRMED DAN MONTANO'S ONE MILLION DOLLAR CLAIM AGAINST CVBT/VENTURIS THERAPEUTICS
Furthermore, with Zhittya Genesis Medicine and Mrs. Montano being ENTIRELY DISMISSED from the lawsuits that Venturis brought fourth there is a clear path for Mr. Daniel Montano to forcibly collect on his 1 million dollar claim. Venturis is at the hands of Dan Montano! Why were we not made aware of this? Why is our administration so quick to announce when lawsuits are filed but not when we are miserably defeated and punished for our defeat?
I worry that Mr. Montano will wipe Venturis off the face of the map with his new ability to forcibly collect on his one million dollar award which has been confirmed by the United States Federal Court.
Daniel C. Montano wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021.
Dan Montano's Clear Victory over CVBT
CardioVascular BioTherapeutics/Venturis Therapeutics has lost yet another court battle to Dan Montano. As a result of this miserable defeat, the US Federal Court has confirmed Dan Montano's $1 million dollar judgment against CVBT/Venturis Therapeutics despite bringing on the case themselves!
Despite what individuals say on this page, there is no right of offset to this matter! Dan Montano's $1 million dollar judgement has no offset. The Court Records clearly indicate the Dan Montano's $1 million dollar judgement. Those same Court Records DO NOT INDICATE THAT VENTURIS THERAPEUTICS IS OWED ANYTHING FROM DAN MONTANO. There is no right of offset. We can only hope that Dan Montano will not initiate a debtor's exam.
CVBT/VT LAWYERS ADMIT CVBT/VT IS WORTHLESS IN FEDERAL COURT
The truth about Cardiovascular Biotherapeutics/Venturis Therapeutics is coming out as a result of the lawsuit they have filed against our former administration.
Our own lawyers were forced to withdraw themselves from the case as a result of Cardiovascular Biotherapeutics'/Venturis Therapeutics' inability to pay the company's lawyers.
As bad as that may sound, this is not all, the company's lawyer then went on to state: Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
Our own lawyers admitted in Federal District Court the incompetence of our administration. We are a worthless company. The United States Federal Court states it in their records, our own lawyers state it, our former administrative members say it.
Cardiovascular Biotherapeutics/Venturis Therapeutics is officially worthless.
"it has become evident that there are currently no assets or revenue streams from which payments can be made."
It gets worse. Not only did our company's lawyers withdraw themselves from Cardiovascular Biotherapeutics/Venturis Therapeutics' lawsuit in federal court, they have also emphasized how defunct Venturis Therapeutics/CVBT truly is in a statement to the United States Federal Court. I have posted another excerpt:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 23-25 read as follows:
"Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made."
"...unpaid fees in excess of $200,000..."
I was able to get my hands on some court documents and was able to find more about why CVBT/VT's lawyers have withdrawn themselves from their suit in Federal District Court. It appears that we did not have enough money to pay them. I have posted an excerpt here:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 15-17 are as follows:
Further, as of March 31, 2021, Venturis owed Mr. Cannaday’s law firm, Dentons US LLP (“Dentons”), unpaid fees in excess of $200,000 for representation in this Previously Closed Case and for representation in the underlying arbitration.
"Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement."
I have managed to obtain some court documents further ellaborating why our company's lawyer has withdrawn himself from the case. I have posted an excerpt here:
UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC.,
formerly known as CARDIOVASCULAR
BIOTHERAPEUTICS, INC.
Claimant,
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN
THE ALTERNATIVE, MOTION TO
WITHDRAW AS COUNSEL FOR
VENTURIS THERAPEUTICS, INC.
Page 3, Line 16 Reads as follows:
However, Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement.
$1,100,000 awarded to Daniel C. Montano by the US Federal Court against CVBT/VT
The United States Federal court has confirmed Daniel C. Montano's $1.1 million dollar judgement against CVBT/VT as a result of their fraudulent and frivolous lawsuit claiming that Daniel C. Montano's IP was not his.
The US Federal Court not only confirmed that Daniel C. Montano has a $1 million dollar (non-off-settable) judgement against CVBT/VT, but that Daniel C. Montano and Zhittya Genesis Medicine own all of their IP.
Daniel C. Montano announces that the US Federal Court has confirmed his IP
The United States Federal Court has confirmed the ruling in favor of Daniel C. Montano citing that Dan Montano owns all of the IP that he and his company, Zhittya Genesis Medicine are developing.
The United States Federal Court's confirmation comes as a result of Cardiovascular Biotherapeutics/ Venturis Therapeutics' own management team testifying in favor of Daniel C. Montano, stating that the IP that Dan Montano and Zhittya Genesis Medicine have been developing are 100% theirs.
Daniel C Montano Announces His Victory over CVBT/VT
Despite years of fraudulent and frivolous lawsuits it appears that Daniel C Montano is now victorious over the crooks that run Cardiovascular Biotherapeutics/Venturis Therapeutics.
Daniel C. Montano has been awarded an over $1 million dollar judgment against CVBT/VT as a result of the frivolous lawsuit that they had originally filed.
Daniel C. Montano's more than $1,000,000 dollar judgement against Cardiovascular BioTherapeutics/Venturis Therapeutics has been confirmed by the United States Federal Court System.
Dan Montano's clear victory over CVBT/VT could result in a forced debtors exam against CVBT/VT in order for Montano to collect on his judgement.
Daniel C Montano has announced that he has won a $1 million dollar judgement against CVBT
Daniel C. Montano has announced that he has won a $1 million dollar judgement against Cardiovascular Biotherapeutics/Venturis Therapeutics confirmed by the US Federal Court. The judge dismissed all of CVBT/VT's claims against Dan Montano. Our current administration's takeover in 2014 has resulted in CVBT/VT suing Daniel C. Montano 10 different times to stop him from developing FGF-1. Each time CVBT/VT has lost to Daniel C. Montano, resulting in astounding victories for Dan Montano.
CVBT/VT's three biotech experts all independently testified that Dan Montano was innocent from the fraudulent claims made by CVBT/VT management.
The most recent court judgement has not only given Daniel C. Montano the ability to actively pursue the fraudulent claimants in order to satisfy his $1 million dollar judgement, but also has given Dan Montano the ability to actively focus on developing FGF-1 at Zhittya Genesis Medicine which has now initiated two Phase I Clinical Trials in Parkinson's Disease and ALS.
Daniel C Montano announces that he wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021
Daniel C. Montano announced that he has won a judgement against CVBT/VT
Daniel C. Montano has announced that he has won a $1 million dollar judgement against Cardiovascular Biotherapeutics/Venturis Therapeutics confirmed by the US Federal Court. The judge dismissed all of CVBT/VT's claims against Dan Montano. Our current administration's takeover in 2014 has resulted in CVBT/VT suing Daniel C. Montano 10 different times to stop him from developing FGF-1. Each time CVBT/VT has lost to Daniel C. Montano, resulting in astounding victories for Dan Montano.
CVBT/VT's three biotech experts all independently testified that Dan Montano was innocent from the fraudulent claims made by CVBT/VT management.
The most recent court judgement has not only given Daniel C. Montano the ability to actively pursue the fraudulent claimants in order to satisfy his $1 million dollar judgement, but also has given Dan Montano the ability to actively focus on developing FGF-1 at Zhittya Genesis Medicine which has now initiated two Phase I Clinical Trials in Parkinson's Disease and ALS.
Daniel C. Montano has initiated a Debtor's Exam against CVBT/VT
Daniel C. Montano has initiated a Debtor's Exam against CVBT/VT, within the next 30 days the shareholders will know that CVBT/VT has no financial viability and is an empty shell of a company.
I fear that Dan Montano will seize all of the assets, including IP, that CVBT has and will sue the CVBT/VT directors for their actions.
DEBTORS EXAM FOR CARDIOVASCULAR BIOTHERAPEUTICS (CVBT)/VENTURIS THERAPEUTICS
Rumor has it that as a result of Dan Montano's court victory, which has given him a judgment of a $1 million dollar claim against Venturis Therapeutics, confirmed by the Federal Court, that Dan Montano will be seeking a debtors exam for CVBT in the month of May. I am worried that this debtors exam will reveal the true financial position of CVBT/Venturis Therapeutics and make the CVBT directors liable.
How will this debtor's exam affect the future of CVBT? Will there be a future for CVBT following this major legal victory for Daniel C. Montano? Where will CVBT get the $1 million dollars to pay Mr. Dan Montano?
THE UNITED STATES FEDERAL COURT HAS CONFIRMED DAN MONTANO'S ONE MILLION DOLLAR CLAIM AGAINST CVBT/VENTURIS THERAPEUTICS
Furthermore, with Zhittya Genesis Medicine and Mrs. Montano being ENTIRELY DISMISSED from the lawsuits that Venturis brought fourth there is a clear path for Mr. Daniel Montano to forcibly collect on his 1 million dollar claim. Venturis is at the hands of Dan Montano! Why were we not made aware of this? Why is our administration so quick to announce when lawsuits are filed but not when we are miserably defeated and punished for our defeat?
I worry that Mr. Montano will wipe Venturis off the face of the map with his new ability to forcibly collect on his one million dollar award which has been confirmed by the United States Federal Court.
Daniel C. Montano wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021.
Dan Montano's Clear Victory over CVBT
CardioVascular BioTherapeutics/Venturis Therapeutics has lost yet another court battle to Dan Montano. As a result of this miserable defeat, the US Federal Court has confirmed Dan Montano's $1 million dollar judgment against CVBT/Venturis Therapeutics despite bringing on the case themselves!
Despite what individuals say on this page, there is no right of offset to this matter! Dan Montano's $1 million dollar judgement has no offset. The Court Records clearly indicate the Dan Montano's $1 million dollar judgement. Those same Court Records DO NOT INDICATE THAT VENTURIS THERAPEUTICS IS OWED ANYTHING FROM DAN MONTANO. There is no right of offset. We can only hope that Dan Montano will not initiate a debtor's exam.
CVBT/VT LAWYERS ADMIT CVBT/VT IS WORTHLESS IN FEDERAL COURT
The truth about Cardiovascular Biotherapeutics/Venturis Therapeutics is coming out as a result of the lawsuit they have filed against our former administration.
Our own lawyers were forced to withdraw themselves from the case as a result of Cardiovascular Biotherapeutics'/Venturis Therapeutics' inability to pay the company's lawyers.
As bad as that may sound, this is not all, the company's lawyer then went on to state: Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.
Our own lawyers admitted in Federal District Court the incompetence of our administration. We are a worthless company. The United States Federal Court states it in their records, our own lawyers state it, our former administrative members say it.
Cardiovascular Biotherapeutics/Venturis Therapeutics is officially worthless.
"it has become evident that there are currently no assets or revenue streams from which payments can be made."
It gets worse. Not only did our company's lawyers withdraw themselves from Cardiovascular Biotherapeutics/Venturis Therapeutics' lawsuit in federal court, they have also emphasized how defunct Venturis Therapeutics/CVBT truly is in a statement to the United States Federal Court. I have posted another excerpt:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 23-25 read as follows:
"Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made."
"...unpaid fees in excess of $200,000..."
I was able to get my hands on some court documents and was able to find more about why CVBT/VT's lawyers have withdrawn themselves from their suit in Federal District Court. It appears that we did not have enough money to pay them. I have posted an excerpt here:
UNITED STATES DISTRICT COURT DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC., formerly known as CARDIOVASCULAR BIOTHERAPEUTICS, INC.
Claimant
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN THE ALTERNATIVE, MOTION TO WITHDRAW AS COUNSEL FOR VENTURIS THERAPEUTICS, INC.
Page 3 Lines 15-17 are as follows:
Further, as of March 31, 2021, Venturis owed Mr. Cannaday’s law firm, Dentons US LLP (“Dentons”), unpaid fees in excess of $200,000 for representation in this Previously Closed Case and for representation in the underlying arbitration.
"Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement."
I have managed to obtain some court documents further ellaborating why our company's lawyer has withdrawn himself from the case. I have posted an excerpt here:
UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA
Venturis THERAPEUTICS, INC.,
formerly known as CARDIOVASCULAR
BIOTHERAPEUTICS, INC.
Claimant,
Case No. 2:20-cv-01410-GMN-BNW
NOTICE OF WITHDRAWAL AND IN
THE ALTERNATIVE, MOTION TO
WITHDRAW AS COUNSEL FOR
VENTURIS THERAPEUTICS, INC.
Page 3, Line 16 Reads as follows:
However, Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement.